Cytokeratin 19 Recombinant monoclonal antibody 86250-1-RR proteintech

$149.00
In stock
SKU
86250-1-RR
Catalog No.SizePrice (USD)
86250-1-RR-20UL20 μL$149.00
86250-1-RR-100UL100 μL$449.00
86250-1-RR-10X100UL1 mL (10 x 100 μL vials)$3,592.00
Catalog Number86250-1-RR
SynonymsCK 19, CK19, KRT19, CK-19, Cytokeratin,Keratin
HostRabbit
Reactivityhuman
FormLiquid
FormulationPBS, Azide, Glycerol
ApplicationsWB, IHC, IF/ICC, IF-P, FC (Intra), ELISA
Host / IsotypeRabbit / IgG
Tested Applications — Positive WB detected inT-47D cells, A549 cells, SW480 cells, SK-BR-3 cells, MCF-7 cells, HepG2 cells, HT-29 cells
Tested Applications — Positive IHC detected inhuman colon tissue, human breast cancer tissue, human skin tissue, human stomach cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
Tested Applications — Positive IF-P detected inhuman breast cancer tissue
Tested Applications — Positive IF/ICC detected inMCF-7 cells
Tested Applications — Positive FC (Intra) detected inMCF-7 cells
Recommended Dilutions — Western Blot (WB)WB : 1:5000-1:50000
Recommended Dilutions — Immunohistochemistry (IHC)IHC : 1:1000-1:4000
Recommended Dilutions — Immunofluorescence (IF)-PIF-P : 1:50-1:500
Recommended Dilutions — Immunofluorescence (IF)/ICCIF/ICC : 1:1000-1:4000
Recommended Dilutions — Flow Cytometry (FC) (INTRA)FC (INTRA) : 0.25 ug per 10^6 cells in a 100 µl suspension
Positive WB detected inT-47D cells, A549 cells, SW480 cells, SK-BR-3 cells, MCF-7 cells, HepG2 cells, HT-29 cells
Positive IHC detected inhuman colon tissue, human breast cancer tissue, human skin tissue, human stomach cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
Positive IF-P detected inhuman breast cancer tissue
Positive IF/ICC detected inMCF-7 cells
Positive FC (Intra) detected inMCF-7 cells
Western Blot (WB)WB : 1:5000-1:50000
Immunohistochemistry (IHC)IHC : 1:1000-1:4000
Immunofluorescence (IF)-PIF-P : 1:50-1:500
Immunofluorescence (IF)/ICCIF/ICC : 1:1000-1:4000
Flow Cytometry (FC) (INTRA)FC (INTRA) : 0.25 ug per 10^6 cells in a 100 µl suspension
Tested Reactivityhuman
ClassRecombinant
TypeAntibody
ImmunogenPeptide Predict reactive species
Full Namekeratin 19
Calculated Molecular Weight44 kDa
Observed Molecular Weight44 kDa
GenBank Accession NumberBC002539
Gene SymbolCytokeratin 19
Gene ID (NCBI)3880
RRIDAB_3744751
ConjugateUnconjugated
Purification MethodProtein A purification
UNIPROT IDP08727
Storage BufferPBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20 o C storage. 20ul sizes contain 0.1% BSA.
FC protocol for Cytokeratin 19 antibody 86250-1-RRDownload protocol
IF protocol for Cytokeratin 19 antibody 86250-1-RRDownload protocol
IHC protocol for Cytokeratin 19 antibody 86250-1-RRDownload protocol
WB protocol for Cytokeratin 19 antibody 86250-1-RRDownload protocol
Citations-
DilutionsWB : 1:5000-1:50000 IHC : 1:1000-1:4000 IF-P : 1:50-1:500 IF/ICC : 1:1000-1:4000 FC (INTRA) : 0.25 ug per 10^6 cells in a 100 µl suspension
IsotypeIgG
ClonalityRecombinant
Clone Number250894B1
ConjugationUnconjugated

Cytokeratin 19 (CK19 or KRT19) is a type I (acidic) cytokeratin. It is an intermediate filament protein providing structural rigidity and multipurpose scaffolds in epithelial cells. CK19 is often overexpressed in various cancers (e.g., hepatocellular carcinoma [HCC], pancreatic adenocarcinoma, lung cancer) and serves as a biomarker for hepatic progenitor cells (HPCs) associated with poor prognosis in HCC patients . Additionally, CK19 expression is common in pancreatic and gastrointestinal adenocarcinomasand has been studied as a potential diagnostic and prognostic marker for pancreatic neuroendocrine tumors (PNETs), where positive CK19 expression correlates with poor prognosis. Serum CK19 fragments (e.g., CYFRA 21-1, CK19-2G2) have been investigated as tumor markers for lung and breast cancer, with preoperative levels associated with metastasis and survival. Protocols Product Specific Protocols FC protocol for Cytokeratin 19 antibody 86250-1-RR Download protocol IF protocol for Cytokeratin 19 antibody 86250-1-RR Download protocol IHC protocol for Cytokeratin 19 antibody 86250-1-RR Download protocol WB protocol for Cytokeratin 19 antibody 86250-1-RR Download protocol Standard Protocols Click here to view our Standard Protocols

Reviews

Write Your Own Review
You're reviewing:Cytokeratin 19 Recombinant monoclonal antibody 86250-1-RR proteintech
Your Rating
Copyright © 2025 Biogege, Inc. All rights reserved.